HealthStream (NASDAQ:HSTM) Stock: Insider Kevin O’hara Sells 4,000 Shares

HealthStream, Inc. (NASDAQ:HSTM) EVP Kevin O’hara sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $31.11, for a total transaction of $124,440.00. Following the completion of the transaction, the executive vice president directly owned 18,901 shares in the company, valued at approximately $588,010.11. The trade was a 17.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

HealthStream Trading Down 2.4%

Shares of HSTM stock opened at $28.89 on Friday. HealthStream, Inc. has a 12 month low of $19.50 and a 12 month high of $35.60. The stock has a market cap of $844.17 million, a P/E ratio of 41.27, a P/E/G ratio of 3.01 and a beta of 0.45. The company has a 50 day simple moving average of $31.20 and a two-hundred day simple moving average of $25.83.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings results on Monday, November 2nd. The technology company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.02. HealthStream had a net margin of 6.25% and a return on equity of 6.37%. The business had revenue of $83.31 million for the quarter, compared to the consensus estimate of $82.24 million. As a group, equities analysts forecast that HealthStream, Inc. will post 0.80 earnings per share for the current year.

HealthStream Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Monday, November 16th will be given a dividend of $0.0350 per share. The ex-dividend date is Monday, November 16th. This represents a $0.14 annualized dividend and a yield of 0.5%. HealthStream’s dividend payout ratio (DPR) is 20.00%.

HealthStream News Roundup

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: Buy rating upgrade: Zacks upgraded HSTM to Rank #2 (Buy), citing improving earnings prospects, which could support investor optimism. Zacks article
• Positive Sentiment: Raised guidance: HealthStream lifted its outlook, a potentially positive sign for expected business performance, although the article raises the question of whether prior gains already reflect the news. Yahoo Finance article
• Neutral Sentiment: Analyst views remain cautious: Canaccord Genuity raised its price target to $32 from $29 but maintained a Hold rating; Craig Hallum also moved its rating to Hold. These calls suggest limited conviction despite the higher target. Canaccord rating information Craig Hallum rating article
• Negative Sentiment: Multiple insider sales: On November 5, EVP Michael Manning Collier, CFO Scott Alexander Roberts, Director Deborah Tate and EVP Kevin O’Hara sold a combined 38,081 shares. Each reduced their individual holdings, a cluster of transactions that may weigh on sentiment, though insider sales alone do not establish a change in the company’s outlook. Collier SEC filing Roberts SEC filing Tate SEC filing O’Hara SEC filing

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HSTM shares. Weiss Ratings upgraded shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Wall Street Zen downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a report on Sunday. Citigroup reaffirmed a “market perform” rating on shares of HealthStream in a report on Tuesday, October 27th. Canaccord Genuity Group lifted their price target on HealthStream from $29.00 to $32.00 and gave the stock a “hold” rating in a research report on Wednesday. Finally, Freedom Capital raised HealthStream to a “hold” rating in a research note on Tuesday, October 13th. One investment analyst has rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, HealthStream currently has an average rating of “Hold” and a consensus price target of $36.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of HSTM. Aberdeen Group plc bought a new position in HealthStream during the 3rd quarter valued at about $2,987,000. Russell Investments Group Ltd. raised its position in HealthStream by 12.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 92,038 shares of the technology company’s stock worth $2,736,000 after purchasing an additional 9,882 shares during the period. Illinois Municipal Retirement Fund raised its position in HealthStream by 3.7% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 11,755 shares of the technology company’s stock worth $349,000 after purchasing an additional 423 shares during the period. Bridge City Capital LLC lifted its stake in HealthStream by 17.6% in the third quarter. Bridge City Capital LLC now owns 60,860 shares of the technology company’s stock worth $1,808,000 after purchasing an additional 9,095 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in HealthStream in the third quarter worth about $160,000. 69.58% of the stock is owned by hedge funds and other institutional investors.

HealthStream Company Profile

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.